• The Power of AI in Cancer Research

    SU2C’s SVP of Science Programs, Cathy Higgins, was recently a panelist at the Spring 2025 Health Research Alliance (HRA) Members Meeting, held virtually March 10–13, 2025. The session, titled The Potential for AI in Discovery Science, brought together thought leaders to explore how artificial intel [...]

  • SU2C Team Developing Early-Stage Detection Technology for Gastric Cancer

    Gastric cancer is the third-leading cause of cancer death worldwide. Often detected too late, it has a five-year survival rate of only 32%. Early-stage detection presents a significant opportunity to change these outcomes. Andrew Chan, M.D., M.P.H, a gastroenterologist physician-epidemiologist at M [...]

  • Cancer Treatment: Advances in the 20th and 21st Centuries

    Written by: Catherine L. Higgins, Stephen M. Rosenberg, Benjamin R. Schroeder, Sarah B. Hart, Julian Adams 20th Century The reviewer of cancer research history can only marvel at the acceleration of drug discovery and development plus the multimodal and multidisciplinary innovations. The landscap [...]

  • First-of-its-Kind Clinical Trial Eliminated or Shrunk Melanoma Tumors in 70% of Patients

    Stand Up To Cancer-Supported Trial Combined Targeted Therapy and Immunotherapy Before Surgery A clinical trial supported by Stand Up To Cancer® (SU2C) has shown that a new drug combination utilized before surgery completely eliminated or shrunk melanoma tumors in 70% of trial participants. The pha [...]

  • Sarcoma Clinical Trial Funded By Stand Up To Cancer Reduces Risk Of Relapse By 43%

    Research Will Likely Impact the Standard of Care for Two Types of Sarcoma For the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare cancers that affect muscles, fat, and other connective tissues. Today, a global team of researchers funded by a Stand Up To C [...]

  • Impact at a Glance

    Doctor and patient holding placards showcasing their support for groups affected by cancer.
    0+
    INSTITUTIONS
    0+
    RESEARCHERS
    0+
    CLINICAL TRIALS
    0+
    RESEARCH TEAMS
    0+
    CLINICAL TRIAL PATIENTS

  • Fund Research. Donate!

    Stand Up To Cancer is a leader in innovative cancer research, bringing together the best and brightest to create new groundbreaking therapies and treatments.

    Secure Payment